What To Expect From Agilent's (A) Q4 Earnings
Life sciences tools company Agilent Technologies (NYSE:A) will be reporting earnings this Wednesday afternoon. Here’s what you need to know.
Agilent beat analysts’ revenue expectations last quarter, reporting revenues of $1.86 billion, up 9.4% year on year. It was a satisfactory quarter for the company, with a narrow beat of analysts’ revenue estimates.
This quarter, the market is expecting Agilent’s revenue to grow 7.4% year on year, improving from the 1.4% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Agilent rarely misses Wall Street’s revenue estimates.
Looking at Agilent’s peers in the research tools & consumables segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Bio-Techne posted flat year-on-year revenue, beating analysts’ expectations by 2%, and Revvity reported revenues up 5.8%, topping estimates by 1.1%. Bio-Techne traded up 1.9% following the results while Revvity was down 7%.
The euphoria surrounding Trump’s November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the research tools & consumables stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.5% on average over the last month. Agilent is down 8.4% during the same time and is heading into earnings with an average analyst price target of $169.67 (compared to the current share price of $124.20).
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tech, Media & Telecom Roundup: Market Talk
Davide Campari-Milano Target Raised to EUR7.00 From EUR6.10 by UBS
Davide Campari-Milano Raised to Buy From Neutral by UBS
VIPMiddle East Tensions Raise Rate Risks but May Create Buying Opportunities
1. The sharp escalation in Middle East tensions pushed Brent crude to multi-year highs of $105–$107 per barrel, reviving inflation expectations. The 10-year U.S. Treasury yield surged to 4.94%, its highest level since 2023, while the implied probability of a rate hike at the September 16 policy meeting to the 3.75%–4.00% range rose from 48.4% one month ago to 67.1%. 2. Rising oil prices and rate-hike expectations weighed on most risk assets, but historical data suggest that this is more likely to be a short-term adjustment than a reversal of the broader trend. Bitcoin fell 3.36% this week and the S&P 500 declined 1.64%, while gold slipped just 0.96%. Outside the energy sector, markets are largely repricing ahead of next week's expected rate decision. 3. PoolX has recently introduced a long-term holding bonus, significantly improving effective returns for users who maintain assets on the platform over time. The core participation rules remain unchanged; the update adds an additional boost to the effective locked amount for users with qualifying long-term holdings. In the example provided, a user locking 1000 ETH would see the estimated reward increase from 1666.67 USDT to 2500 USDT, or about 50%, while the reference APR rises from 4.93% to 7.40%. Assets to watch: BTC, ETH, SOL, Brent crude, WTI crude, gold, 10-year U.S. Treasuries, RAY, ZEC, LEN, CCL.

